Opioid03-14-25

Summary

Meeting Overview

The Opioid Abatement Commission met on October 11, 2024, with Dr. Stephanie Raglan presiding over the session. The meeting featured one agenda item — a presentation on the Substance Abuse Intervention Program, which was informational in nature. Over the course of the meeting, the Commission took 3 votes and heard no public comments.

Attendance

The following members were recorded for the meeting held on 2025-03-19.

Present: - Dr. Stephanie Raglan - Tara Stanfield - Kimberly Baird - Sierra Bowman - John Moses - Margaret Pesciano - Dale Sanders - Dr. Matt Webster - Dr. Mark Woods

Absent: - Connie Neal - Lori Brock - Angela Evans

No members were recorded as late. A total of nine members were present and three were absent.

Votes and Decisions

Three voice votes were taken during the March 19, 2025 meeting, all of which passed.

• Adoption of the Proposed Agenda 8:10: Dale Sanders moved to adopt the proposed agenda. The motion passed by voice vote.

• Approval of the February 14, 2025 Minutes 10:39: Sierra Bowman moved to approve the minutes from the February 14, 2025 meeting, with a second from Angela Evans. The motion passed by voice vote.

• Motion to Close the Meeting 49:47: Mark moved to close the meeting, with a second from Margaret. The motion passed by voice vote.

All three votes were conducted by voice, and no roll call votes were recorded. No nays or abstentions were noted for any of the motions.

Appointments

The following individuals were reappointed to the Opioid Abatement Commission at the March 19, 2025 meeting:

• Dr. Stephanie Raglan was reappointed to the Opioid Abatement Commission.
• Connie Neal was reappointed to the Opioid Abatement Commission.
• Tara Stanfield was reappointed to the Opioid Abatement Commission.
• Kimberly Baird was reappointed to the Opioid Abatement Commission.
• Angela Evans was reappointed to the Opioid Abatement Commission.

All five reappointments were to the same body, continuing the service of each member on the Opioid Abatement Commission. No new appointments to other boards or commissions were recorded at this meeting.

Substance Abuse Intervention Program Presentation

19:30

Carmen and Scott Llewellyn presented to the body on the Substance Abuse Intervention Program, focusing on efforts to address overdose deaths and substance use disorders in the community.

The presentation covered the following key areas:

• Funding Continuity: The speakers emphasized the importance of maintaining and continuing funding opportunities to sustain the program's operations and services.
• Partnerships: Carmen and Scott Llewellyn highlighted the role of partnerships in supporting the program's mission to combat substance use disorders and reduce overdose deaths.
• Overdose and Substance Use Concerns: The presentation addressed the ongoing public health challenges posed by overdose deaths and substance use disorders, underscoring the need for sustained intervention efforts.

The item was informational in nature, with no formal vote or action taken as a result of the presentation.